Multiple Myeloma Clinical Trials

Role of Microenvironmental-Derived AXII in Myeloma Bone Disease An Exploratory Model

The purpose of this research is to learn if substances that cause bone destruction are increased in multiple myeloma patient's blood or bone marrow.

A Path Analysis Modeling of the Interaction of AXII and/or AXIIR with the Changes in Cytokines and Myeloma Bone Disease

The purpose of this research study is to learn if substances that cause bone destruction are increased in the blood or bone marrow.

Tissue Procurement Protocol for the Developmental Therapeutics Clinic National Cancer Institute (NCI)

The purpose of this study is to obtain samples for research purposes from tests performed for clinical indications or research indications on other research protocols, and to obtain samples for research purposes from non-surgical procedures, performed for the sole purpose of obtaining samples for this protocol.

Predicting Progression of Developing Myeloma in a High Risk-Screened Population (PROMISE)

  Before a person develops multiple myeloma, their marrow begins to make abnormal cells and proteins, which can be an early warning sign of the disease. We're inviting qualifying adults with higher risks for multiple myeloma to participate in a screening study for early warning signs of the disease.

IUCRO-0498; Role of Osteocytes in Myeloma Bone Disease

The purpose of this study is to learn if substances that may cause bone destruction are increased in blood or bone marrow.

STEPS to Enhance Physical Activity (STEPS) after Hematopoietic Stem Cell Transplantation (HCT) for Multiple Myeloma

The purpose of this pilot study is to test the preliminary effects of a free-living physical activity intervention, STEPS to Enhance Physical Activity (STEPS), compared to usual care on fatigue (tiredness), functional ability (ability to perform tasks associated with daily living, like moving from a sitting to standing position), muscle …

A Study to Confirm Safety and Efficacy of BAN2401 in Subjects With Early Alzheimer's Disease

BAN2401 is an investigational study drug which is being studied in people who have early AD (Alzheimer's disease), with mild cognitive (thinking) impairment or mild dementia. People with AD have a build-up of abnormal protein known as amyloid in their brains.  This build up may lead to impairment in memory …

None

None